Organigram (OGI) Short Interest Ratio & Short Volume → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free OGI Stock Alerts $2.02 -0.01 (-0.49%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Organigram Short Interest DataCurrent Short Volume3,860,000 sharesPrevious Short Volume3,580,000 sharesChange Vs. Previous Month+7.82%Dollar Volume Sold Short$8.18 millionShort Interest Ratio / Days to Cover2.5Last Record DateApril 30, 2024Outstanding Shares103,370,000 sharesFloat Size65,810,000 sharesShort Percent of Float5.87%Today's Trading Volume1,635,200 sharesAverage Trading Volume1,432,614 sharesToday's Volume Vs. Average114% Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatOGI Short Interest Over TimeOGI Days to Cover Over TimeOGI Percentage of Float Shorted Over Time Ad The Freeport SocietyBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. Organigram Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,860,000 shares $8.18 million +7.8%5.9%2.5 $2.12 4/15/20243,580,000 shares $6.73 million +0.3%5.4%2.5 $1.88 3/31/20243,570,000 shares $7.68 million +0.6%5.4%2.5 $2.15 3/15/20243,550,000 shares $7.35 million -0.3%5.4%3.4 $2.07 2/29/20243,560,000 shares $7.37 million -14.6%5.4%3.9 $2.07 2/15/20244,170,000 shares $8.38 million +4.0%6.8%4.8 $2.01Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. 1/31/20244,010,000 shares $6.66 million +1.5%7.6%4.6 $1.66 1/15/20243,950,000 shares $6.68 million +2.1%6.0%2.9 $1.69 12/31/20233,870,000 shares $5.07 million -7.9%5.9%3.2 $1.31 12/15/20234,200,000 shares $5.59 million -1.2%6.4%3.5 $1.33 11/30/20234,250,000 shares $5.44 million +1.2%6.5%3.5 $1.28 11/15/20234,200,000 shares $5.25 million +30.8%6.4%3.4 $1.25 10/31/20233,210,000 shares $3.37 million +6.6%4.9%2.7 $1.05 10/15/20233,010,000 shares $3.46 million +7.1%4.6%6.1 $1.15 9/30/20232,810,000 shares $3.71 million No Change4.3%4.7 $1.32 9/15/20232,810,000 shares $5.11 million +7.7%4.3%4.7 $1.82 8/31/20232,610,000 shares $4.28 million +17.6%4.0%4.9 $1.64 8/15/20232,220,000 shares $2.93 million -11.2%3.4%4.8 $1.32 7/31/20232,500,000 shares $3.80 million +3.7%3.8%5.7 $1.52 7/15/20232,410,000 shares $3.76 million +1.3%3.7%6.4 $1.56 6/30/20232,380,000 shares $3.71 million -73.9%N/A7.8 $1.56 6/15/20239,120,000 shares $3.76 million -14.6%N/A8.9 $0.41 5/31/202310,680,000 shares $3.96 million +22.1%N/A10.4 $0.37 5/15/20238,750,000 shares $4.11 million No ChangeN/A10.3 $0.47 4/30/20238,750,000 shares $4.38 million +26.1%N/A10.6 $0.50 4/15/20236,940,000 shares $3.85 million +7.9%N/A7.8 $0.56 3/31/20236,430,000 shares $4.12 million -0.3%N/A6.1 $0.64 3/15/20236,450,000 shares $4.13 million -3.3%N/A6 $0.64 2/28/20236,670,000 shares $5.26 million +23.8%N/A5.7 $0.79 2/15/20235,390,000 shares $4.54 million -11.8%N/A4.3 $0.84 1/31/20236,110,000 shares $5.55 million -1.0%N/A4.8 $0.91 1/15/20236,170,000 shares $6.11 million -17.0%N/A4.9 $0.99 12/30/20227,430,000 shares $5.94 million -4.6%N/A6.6 $0.80 12/15/20227,790,000 shares $6.93 million -4.0%N/A6.5 $0.89 11/30/20228,110,000 shares $8.35 million -8.2%N/A6.9 $1.03 11/15/20228,830,000 shares $9.01 million +2.7%N/A8.6 $1.02 10/31/20228,600,000 shares $8.77 million -15.6%N/A6.7 $1.02 10/15/202210,190,000 shares $9.21 million +12.2%N/A7.4 $0.90 9/30/20229,080,000 shares $7.91 million +3.2%N/A5.1 $0.87 9/15/20228,800,000 shares $9.06 million +1.6%N/A4.9 $1.03Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. OGI Short Interest - Frequently Asked Questions What is Organigram's current short interest? Short interest is the volume of Organigram shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 3,860,000 shares of OGI short. 5.87% of Organigram's shares are currently sold short. Learn More on Organigram's current short interest. What is a good short interest ratio for Organigram? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OGI shares currently have a short interest ratio of 2.0. Learn More on Organigram's short interest ratio. What is a good short interest percentage for Organigram? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.87% of Organigram's floating shares are currently sold short. Is Organigram's short interest increasing or decreasing? Organigram saw a increase in short interest in April. As of April 30th, there was short interest totaling 3,860,000 shares, an increase of 7.8% from the previous total of 3,580,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Organigram's float size? Organigram currently has issued a total of 103,370,000 shares. Some of Organigram's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Organigram currently has a public float of 65,810,000 shares. How does Organigram's short interest compare to its competitors? 5.87% of Organigram's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Organigram: Acrivon Therapeutics, Inc. (5.22%), Inventiva S.A. (0.13%), Atossa Therapeutics, Inc. (9.10%), Incannex Healthcare Inc. (0.48%), Lifecore Biomedical, Inc. (6.60%), Zevra Therapeutics, Inc. (6.15%), Galectin Therapeutics Inc. (7.35%), Greenwich LifeSciences, Inc. (3.24%), Trevi Therapeutics, Inc. (1.49%), Alimera Sciences, Inc. (0.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Organigram stock? Short selling OGI is an investing strategy that aims to generate trading profit from Organigram as its price is falling. OGI shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Organigram? A short squeeze for Organigram occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OGI, which in turn drives the price of the stock up even further. How often is Organigram's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OGI, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Acrivon Therapeutics Short Squeeze Inventiva Short Squeeze Atossa Therapeutics Short Squeeze Incannex Healthcare Short Squeeze Lifecore Biomedical Short Squeeze Zevra Therapeutics Short Squeeze Galectin Therapeutics Short Squeeze Greenwich LifeSciences Short Squeeze Trevi Therapeutics Short Squeeze Alimera Sciences Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OGI) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubBill Gates is all about this tiny $2 stockTimothy Sykes